Paper Details 
Original Abstract of the Article :
BACKGROUND: Immunosuppressive therapy post-kidney transplantation is usually used continuously and should be regularly monitored. Inadequate dosages of immunosuppressive drugs and lack of regular monitoring can lead to either severe side effects or allograft rejection. AIM: To study the hematologic...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.transproceed.2011.01.077

データ提供:米国国立医学図書館(NLM)

Navigating the Desert of Immunosuppression: Balancing the Scales of Rejection and Side Effects

Kidney transplantation, a delicate balancing act between preventing rejection and minimizing side effects, can be a challenging journey, like navigating a vast and unforgiving desert. This study investigates the hematologic side effects of two commonly used immunosuppressant drugs, azathioprine and mycophenolate, in kidney transplant recipients. The researchers monitored the blood counts of 59 patients who received both drugs and found that both medications had similar hematologic effects, with no significant differences in overall blood cell counts. However, they observed that azathioprine was associated with increased red blood cell size and iron levels, while mycophenolate was associated with increased white blood cell counts. The study highlights the importance of careful monitoring and individualized adjustments to ensure optimal outcomes for kidney transplant recipients.

A Personalized Compass: Tailoring Immunosuppression to Individual Needs

This study underscores the importance of personalized medicine in managing immunosuppression after kidney transplantation. The researchers found that while both azathioprine and mycophenolate have similar hematologic effects, individual patients may experience different side effects. This highlights the need for careful monitoring and individualized adjustments to ensure optimal outcomes and minimize side effects.

Balancing the Scales of Immunosuppression: A Guide Through the Desert

This study offers valuable insights into the hematologic side effects of two commonly used immunosuppressant drugs, azathioprine and mycophenolate, in kidney transplant recipients. By understanding the potential side effects of these medications and developing strategies for managing them, healthcare providers can better navigate the desert of immunosuppression, ensuring optimal outcomes and minimizing side effects for patients.

Dr.Camel's Conclusion

This study compares the hematologic side effects of azathioprine and mycophenolate in kidney transplant recipients, highlighting the importance of individualized monitoring and adjustments to optimize outcomes and minimize side effects. The research underscores the need for a personalized approach to managing immunosuppression in this complex patient population.
Date :
  1. Date Completed 2011-07-22
  2. Date Revised 2016-11-25
Further Info :

Pubmed ID

21440745

DOI: Digital Object Identifier

10.1016/j.transproceed.2011.01.077

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.